The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China

INTRODUCTION: New targeted therapies have changed cancer treatment in the past decades. However, high prices of targeted anticancer medications have increased economic burden for both patients and health insurance systems. In July 2017, China implemented combined medication price negotiation and man...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yichen, Wushouer, Haishaerjiang, Han, Sheng, Fu, Mengyuan, Guan, Xiaodong, Shi, Luwen, Wagner, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286756/
https://www.ncbi.nlm.nih.gov/pubmed/34266848
http://dx.doi.org/10.1136/bmjgh-2021-006196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286756/
https://www.ncbi.nlm.nih.gov/pubmed/34266848
http://dx.doi.org/10.1136/bmjgh-2021-006196

Ejemplares similares